Haw Par (Haw Par) 5-Year EBITDA Growth Rate : 0.50% (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Haw Par 5-Year EBITDA Growth Rate?

Haw Par's EBITDA per Share for the six months ended in Dec. 2023 was $0.42.

During the past 12 months, Haw Par's average EBITDA Per Share Growth Rate was 43.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 21.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 0.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Haw Par was 21.90% per year. The lowest was -14.90% per year. And the median was 5.75% per year.

Competitive Comparison of Haw Par's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, Haw Par's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haw Par's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haw Par's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Haw Par's 5-Year EBITDA Growth Rate falls into.

Haw Par 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Haw Par (OTCPK:HAWPF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Haw Par 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Haw Par's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Haw Par (Haw Par) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haw Par Corp Ltd (OTCPK:HAWPF) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

H02:Singapore

Address

401 Commonwealth Drive, No. 03-03 Haw Par Technocentre, Singapore, SGP, 149598

Website

https://www.hawpar.com

Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates a majority of its revenue from the ASEAN countries.

Haw Par (Haw Par) Headlines

From GuruFocus

Singapore Based Haw Par Selling at a Discount to NAV

By Holmes Osborne, CFA Holmes Osborne, CFA • 07-26-2016

Haw Par Stock Is Believed To Be Significantly Overvalued

By GF Value GF Value • 03-31-2021

First Eagle Comments on Haw Par

By Holly LaFon Holly LaFon • 04-24-2018